Skip to main content
OpenTrials

Clinical trial condition

ER+ Breast Cancer

Explore clinical trials studying ER+ Breast Cancer. Study availability and eligibility vary by location and protocol.

22 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

ER+ Breast Cancer trial results

Active, Not Recruiting

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

NCT06590857

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Research Facility Phoenix, Arizona, United States
  • Research Facility Irvine, California, United States
  • Research Facility San Diego, California, United States
  • Research Facility Santa Monica, California, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details

Related conditions